+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Multicenter randomized trial of 15mcg Alfacon-1 administered daily vs thrice weekly in patients with chronic hepatitis C who did not respond to interferon therapy Initial response and tolerability



Multicenter randomized trial of 15mcg Alfacon-1 administered daily vs thrice weekly in patients with chronic hepatitis C who did not respond to interferon therapy Initial response and tolerability



Gastroenterology 118(4 Suppl 2 Part 2): AASLD A143




(PDF emailed within 0-6 h: $19.90)

Accession: 035349915

Download citation: RISBibTeXText

DOI: 10.1016/S0016-5085(00)81650-9


Related references

Muticenter randomized trial of 15 mcg Infergen administered daily vs thrice weekly in pts with chronic hepatitis C who did not respond to interferon therapy. Hepatology 32(4 Pt 2): 349A, 2000

Comparison of daily interferon alfacon-1 with standard regimens of thrice weekly interferon alfacon-1 in patients with chronic hepatitis C Interim results from an ongoing international Trial. Journal of Hepatology 34(Supplement 1): 177, 2001

Daily vs thrice weekly interferon in combination with ribavirin for patients with chronic hepatitis C infection Preliminary results of a multicenter randomized trial. Gastroenterology 120(5 Supplement 1): A 571, 2001

Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes 35(5): 464-472, 2004

Preliminary results of a randomized multicenter controlled trial comparing interferon thrice weekly in combination with ribavirin with interferon daily in combination with ribavirin and amantadine in the treatment of chronic hepatitis C in human immune deficiency virus co-infected patients. Hepatology 36(4 Part 2): 586A, 2002

Daily or twice daily interferon alfacon-1 administration achieves optimal viral suppression compared to thrice weekly dosing schedules in subjects with genotype 1 chronic hepatitis C virus infection. Hepatology 30(4 PART 2): 198A, 1999

A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection. Journal of Gastroenterology and Hepatology 15(10): 1165-1170, 2000

Triple therapy with daily induction Interferon-alpha2a , Ribavirin and Amantadine for patients with chronic hepatitis C , who failed to respond to a previous combination treatment protocol Single arm open label pilot study Initial response, safety and tolerability. Hepatology 32(4 Pt 2): 559A, 2000

The importance of initial daily administration of interferon alpha for the eradication of hepatitis C virus in patients with chronic hepatitis C: a multicenter randomized trial. Hepato-Gastroenterology 45(22): 1045-1055, 1998

A multicenter, randomized, controlled clinical trial of interferon alfacon-1 in comparison with lymphoblastoid interferon-alpha in patients with high-titer chronic hepatitis C virus infection. Hepatology Research 22(1): 1-12, 2002

High dose interferon treatment for chronic hepatitis C Daily induction vs thrice weekly therapy. Gastroenterology 118(4 Suppl 2 Part 2): AASLD A148, 2000

First-line therapy with daily versus thrice-weekly interferon alfa-2b plus ribavirin for chronic hepatitis C. European Journal of Gastroenterology and Hepatology 15(12): 1299-1304, 2003

A new insight into the interaction of ZnO with calf thymus DNA through surface defects. Journal of Photochemistry and Photobiology. B, Biology 178: 339-347, 2017

Interferon alfacon-1 induction therapy A multicenter trial in subjects with chronic hepatitis C virus infection. Hepatology 32(4 Pt 2): 369A, 2000

A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients. Journal of Hepatology 3 Suppl 2: S183-S188, 1986